The role of high-density lipoproteins in the regulation of angiogenesis
Date
2015
Authors
Tan, J.
Ng, M.
Bursill, C.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Cardiovascular Research (CVR), 2015; 106(2):184-193
Statement of Responsibility
Joanne T.M. Tan, Martin K.C. Ng, Christina A. Bursill
Conference Name
Abstract
Angiogenesis is important for postnatal physiological processes including tissue neovascularization in response to an ischaemic injury. Conversely, uncontrolled inflammatory-driven angiogenesis can accelerate atherosclerotic plaque and tumour growth. Angiogenesis-associated diseases are highly prevalent globally, with cardiovascular-related disorders and cancer being the leading causes of mortality worldwide. A vast amount of research has been conducted on the vasculoprotective effects of high-density lipoproteins (HDLs) and while current HDL-raising therapies to date have not yielded the desired benefits clinically, its role in angiogenesis is yet to be fully elucidated. Epidemiological studies report positive correlations between elevated HDL levels and improved prognosis in both ischaemia- and inflammatory-driven pathologies, in which angiogenesis plays a key role. This review focuses on current evidence from epidemiological and prospective studies, coupled with animal models and mechanistic studies that highlight the ability of HDL to conditionally regulate angiogenesis.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015.